Peter C. Ray

1.2k total citations
21 papers, 556 citations indexed

About

Peter C. Ray is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Peter C. Ray has authored 21 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Infectious Diseases and 8 papers in Organic Chemistry. Recurrent topics in Peter C. Ray's work include Tuberculosis Research and Epidemiology (8 papers), Computational Drug Discovery Methods (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). Peter C. Ray is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Computational Drug Discovery Methods (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). Peter C. Ray collaborates with scholars based in United Kingdom, United States and South Africa. Peter C. Ray's co-authors include Paul G. Wyatt, Clifton E. Barry, Helena I. Boshoff, Sophie Pelletier, Darren J. Dixon, Simon R. Green, Qinglan Wang, Justin R. Harrison, Stanley M. Roberts and Fabio Zuccotto and has published in prestigious journals such as Science, Antimicrobial Agents and Chemotherapy and Organic Letters.

In The Last Decade

Peter C. Ray

20 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter C. Ray United Kingdom 12 284 256 179 162 52 21 556
Noriaki Iwase Japan 6 266 0.9× 257 1.0× 140 0.8× 113 0.7× 35 0.7× 10 417
Anne Drumond Villela Brazil 14 260 0.9× 244 1.0× 142 0.8× 128 0.8× 31 0.6× 32 453
David Barros-Aguirre Spain 13 253 0.9× 194 0.8× 165 0.9× 102 0.6× 37 0.7× 19 410
Tamara Hess United States 7 364 1.3× 273 1.1× 273 1.5× 122 0.8× 52 1.0× 7 567
Michael Goodwin United States 10 366 1.3× 290 1.1× 210 1.2× 153 0.9× 56 1.1× 14 579
Norio Doi Japan 10 256 0.9× 157 0.6× 199 1.1× 65 0.4× 56 1.1× 20 389
David D. Deininger United States 9 186 0.7× 216 0.8× 107 0.6× 88 0.5× 33 0.6× 14 417
Allen Casey United States 10 250 0.9× 199 0.8× 167 0.9× 104 0.6× 16 0.3× 10 405
Haiming Yuan China 3 266 0.9× 241 0.9× 185 1.0× 55 0.3× 32 0.6× 7 407
Catherine Piveteau France 12 136 0.5× 220 0.9× 82 0.5× 94 0.6× 37 0.7× 25 496

Countries citing papers authored by Peter C. Ray

Since Specialization
Citations

This map shows the geographic impact of Peter C. Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Ray more than expected).

Fields of papers citing papers by Peter C. Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Ray. The network helps show where Peter C. Ray may publish in the future.

Co-authorship network of co-authors of Peter C. Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Ray. A scholar is included among the top collaborators of Peter C. Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Ray. Peter C. Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oh, Sangmi, M. Daben J. Libardo, Shaik Azeeza, et al.. (2021). Structure–Activity Relationships of Pyrazolo[1,5-a]pyrimidin-7(4H)-ones as Antitubercular Agents. ACS Infectious Diseases. 7(2). 479–492. 13 indexed citations
2.
Evans, Joanna C., John Post, V. Mendes, et al.. (2021). Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4′-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) Activity. ACS Infectious Diseases. 7(6). 1666–1679. 6 indexed citations
3.
Libardo, M. Daben J., Caroline J. Duncombe, Simon R. Green, et al.. (2021). Resistance of Mycobacterium tuberculosis to indole 4-carboxamides occurs through alterations in drug metabolism and tryptophan biosynthesis. Cell chemical biology. 28(8). 1180–1191.e20. 9 indexed citations
4.
Wang, Qinglan, Helena I. Boshoff, Justin R. Harrison, et al.. (2020). PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis. Science. 367(6482). 1147–1151. 124 indexed citations
5.
Homeyer, Nadine, Ruud van Deursen, Bernardo Ochoa‐Montaño, et al.. (2019). A platform for target prediction of phenotypic screening hit molecules. Journal of Molecular Graphics and Modelling. 95. 107485–107485.
6.
Park, Yumi, Sangmi Oh, Michael Goodwin, et al.. (2019). Inhibition of CorA-Dependent Magnesium Homeostasis Is Cidal in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 63(10). 9 indexed citations
7.
Prati, Federica, Fabio Zuccotto, Daniel A. Fletcher, et al.. (2018). Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA. ChemMedChem. 13(7). 672–677. 14 indexed citations
8.
Ray, Peter C., et al.. (2016). Fragment library design, synthesis and expansion: nurturing a synthesis and training platform. Drug Discovery Today. 22(1). 43–56. 30 indexed citations
9.
Sarathy, Jansy P., Fabio Zuccotto, Lars Sandberg, et al.. (2016). Prediction of Drug Penetration in Tuberculosis Lesions. ACS Infectious Diseases. 2(8). 552–563. 102 indexed citations
10.
Arora, Kriti, Bernardo Ochoa‐Montaño, Patricia Tsang, et al.. (2014). Respiratory Flexibility in Response to Inhibition of Cytochrome c Oxidase in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 58(11). 6962–6965. 95 indexed citations
11.
Kiyoi, Takao, et al.. (2011). Synthesis of hexahydro[2]benzopyrano[4,3-c]pyridines as serotonin 5-HT2C receptor agonists via intramolecular hetero Diels–Alder reactions. Tetrahedron Letters. 52(27). 3417–3420. 3 indexed citations
12.
13.
Kiyoi, Takao, Mark Reid, Wilson Caulfield, et al.. (2011). Synthesis of hexahydro[2]benzopyrano[3,4-c]pyrroles as serotonin 5-HT2C receptor agonists via intramolecular hetero Diels–Alder reactions. Tetrahedron Letters. 52(27). 3413–3416. 11 indexed citations
14.
Pelletier, Sophie, Peter C. Ray, & Darren J. Dixon. (2011). Diastereoselective Synthesis of 1,3,5-Trisubstituted 4-Nitropyrrolidin-2-ones via a Nitro-Mannich/Lactamization Cascade. Organic Letters. 13(24). 6406–6409. 22 indexed citations
15.
Ray, Peter C., Jane Wright, Julia Adam, et al.. (2010). Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(4). 1084–1088. 18 indexed citations
16.
Quibell, Martin, et al.. (2004). Synthesis and evaluation of cis-hexahydropyrrolo[3,2-b]pyrrol-3-one peptidomimetic inhibitors of CAC1 cysteinyl proteinases. Bioorganic & Medicinal Chemistry. 13(3). 609–625. 8 indexed citations
17.
18.
Bennett, David Jonathan, et al.. (2004). Liver X receptor agonists as a treatment for atherosclerosis. Expert Opinion on Therapeutic Patents. 14(7). 967–982. 5 indexed citations
19.
Ray, Peter C. & Stanley M. Roberts. (2001). Juliá–Colonna stereoselective epoxidation of some α,β-unsaturated enones possessing a stereogenic centre at the γ-position: synthesis of a protected galactonic acid derivative. Journal of the Chemical Society Perkin Transactions 1. 149–153. 11 indexed citations
20.
Ray, Peter C. & Stanley M. Roberts. (1999). Overcoming intrinsic diastereoselection using polyleucine as a chiral epoxidation catalyst. Tetrahedron Letters. 40(9). 1779–1782. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriaki Iwase Breakdown of academic impact, for papers by Anne Drumond Villela Breakdown of academic impact, for papers by David Barros-Aguirre Breakdown of academic impact, for papers by Tamara Hess Breakdown of academic impact, for papers by Michael Goodwin Breakdown of academic impact, for papers by Norio Doi Breakdown of academic impact, for papers by David D. Deininger Breakdown of academic impact, for papers by Allen Casey Breakdown of academic impact, for papers by Haiming Yuan Breakdown of academic impact, for papers by Catherine Piveteau
Rankless by CCL
2026